White Paper: Shared Opportunities
Addressing NCDs: Psoriasis and its Co-Morbidities
People with psoriasis are at greater risk of developing co-morbid conditions. What is notable about psoriasis co-morbidities is that all are NCDs. Psoriasis also shares the same risk factors - tobacco use, unhealthy diet, physical inactivity, and harmful use of alcohol – as other NCDs. Diabetes and cardiovascular diseases are among the most severe psoriasis co-morbidities. At the same time, diabetes and cardiovascular diseases are two out of the four ‘main NCDs’ listed in the Global Action Plan for the Prevention and Control of NCDs (2013-2020), together with cancer and chronic respiratory diseases. Due to the risk of co-morbidities, it is essential that psoriasis is addressed early, closely, holistically and efficiently.
White Paper: Psoriasis and Universal Health Coverage
Psoriasis and Universal Health Coverage
Universal Health Coverage (UHC) is a crucial element to ensure people's access to quality health services without the risk of incurring financial hardship. It is a commitment that the UN Member States made as part of the Sustainable Development agenda.
UHC plays a fundamental role in ensuring quality psoriasis and psoriatic arthritis care at multiple levels. A strong primary healthcare system would ensure early diagnosis, access to a health care provider or specialist and prompt treatment. Moreover, the chronic nature of the disease implies that people living with psoriasis and psoriatic arthritis are subjected to life-long treatment regimens and experience a high share of out-of-pocket expenses. The achievement of UHC will reduce the burden of the disease for people living with psoriasis and will allow multiple economical and societal benefits.
Report: Psoriasis is a Serious Disease Deserving Global Attention
The Impacts of Psoriatic Disease and a Global Call to Action
The report seeks to inform the United Nations and other international organizations, Governments, Ministers of Health, donor countries and global philanthropic institutions, civil society, insurers/payers, health workers and psoriasis patients and their families that psoriasis is a serious inflammatory, noncommunicable autoimmune disease which carries severe physical, mental and socioeconomic burdens on over 125 million people worldwide.